1 Lung Research, Hanson Institute and Department of Thoracic Medicine, Royal Adelaide Hospital, Adelaide, South Australia. 2 Department of Medicine, University of Adelaide, Adelaide, South Australia. 3 South Australian Lung Transplant Service, Adelaide, South Australia.
Transplantation. 2017 Oct;101(10):2469-2476. doi: 10.1097/TP.0000000000001592.
Immunosuppression therapy after lung transplantation fails to prevent bronchiolitis obliterans syndrome (BOS) in many patients, primarily a disease of the small airways. We have reported that BOS is associated with a lack of suppression of cytotoxic mediators, and proinflammatory cytokines, in peripheral blood T, NKT-like (particularly CD8+) and NK cells. We also showed a loss of glucocorticoid receptor (GCR) in proinflammatory lymphocytes after transplant. It is unknown whether these proinflammatory lymphocytes target the small and/or large airways in BOS.
Blood, bronchoalveolar lavage, large proximal, and small distal airway brushings were collected from patients with BOS (n = 10), stable lung transplant patients (n = 18), and healthy aged-matched controls (n = 10). Intracellular cytotoxic mediators (perforin/granzyme B), proinflammatory cytokines (IFNγ/TNFα), and expression of GCR were determined in lymphocytes subsets from cultured blood using flow cytometry.
Increases in CD8 T cells, NKT-like cells, and NK cells were found in the small distal airways in BOS compared with stable patients and controls. An increase in perforin, granzyme B, IFNγ, TNFα, and a loss of GCR from these lymphocyte subsets was also found in BOS. GCR expression by CD8+ T cells from small airways correlated with FEV1 (R = 0.834, P = 0.039). Many of these changes significantly differed from those in the large airways.
BOS is associated with increased cytotoxic/proinflammatory CD8+ T, NKT-like, and NK cells in the small airways. Treatments that increase GCR in these lymphocyte subsets may improve graft survival.
肺移植后免疫抑制治疗未能预防许多患者的细支气管闭塞综合征(BOS),BOS 主要是小气道疾病。我们已经报告说,BOS 与外周血 T、NKT 样(特别是 CD8+)和 NK 细胞中细胞毒性介质和促炎细胞因子的抑制缺乏有关。我们还显示移植后促炎淋巴细胞中的糖皮质激素受体(GCR)丧失。尚不清楚这些促炎淋巴细胞是否靶向 BOS 中的小气道和/或大气道。
从 BOS 患者(n=10)、稳定的肺移植患者(n=18)和健康年龄匹配的对照(n=10)中采集血液、支气管肺泡灌洗、大近端和小远端气道刷洗物。使用流式细胞术测定培养血液中淋巴细胞亚群中的细胞毒性介质(穿孔素/颗粒酶 B)、促炎细胞因子(IFNγ/TNFα)和 GCR 的表达。
与稳定患者和对照相比,BOS 患者的小远端气道中发现 CD8+T 细胞、NKT 样细胞和 NK 细胞增加。BOS 中还发现这些淋巴细胞亚群中的穿孔素、颗粒酶 B、IFNγ、TNFα 和 GCR 的丧失。小气道中 CD8+T 细胞的 GCR 表达与 FEV1 相关(R=0.834,P=0.039)。这些变化中的许多与大气道中的变化明显不同。
BOS 与小气道中细胞毒性/促炎 CD8+T、NKT 样和 NK 细胞的增加有关。增加这些淋巴细胞亚群中 GCR 的治疗方法可能会改善移植物存活率。